Literature DB >> 17659953

Serum osteoprotegerin as a biomarker for vascular disease.

Ann Van Campenhout, Paula Clancy, Jonathan Golledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17659953      PMCID： PMC2000475          DOI： 10.1016/j.amjcard.2007.03.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

1.  Quantification of abdominal aortic calcification on CT.

Authors:  Rumal W Jayalath; Peter Jackson; Jonathan Golledge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02       Impact factor: 8.311

2.  Assessment of a serum assay for quantification of abdominal aortic calcification.

Authors:  Paula Clancy; Lisa Oliver; Rumal Jayalath; Petra Buttner; Jonathan Golledge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-11       Impact factor: 8.311

3.  Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

Authors:  Moeen Abedin; Torbjørn Omland; Thor Ueland; Amit Khera; Pål Aukrust; Sabina A Murphy; Tulika Jain; Ugis Gruntmanis; Darren K McGuire; James A de Lemos
Journal:  Am J Cardiol       Date:  2006-12-28       Impact factor: 2.778

4.  Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease.

Authors:  Shuichi Jono; Yuji Ikari; Atsushi Shioi; Katsuhito Mori; Takami Miki; Kazuhiro Hara; Yoshiki Nishizawa
Journal:  Circulation       Date:  2002-09-03       Impact factor: 29.690

5.  Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels.

Authors:  P Pennisi; S S Signorelli; S Riccobene; G Celotta; L Di Pino; T La Malfa; C E Fiore
Journal:  Osteoporos Int       Date:  2003-12-06       Impact factor: 4.507
  5 in total
  3 in total

1.  Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality.

Authors:  Wolfgang Lieb; Philimon Gona; Martin G Larson; Joseph M Massaro; Izabella Lipinska; John F Keaney; Jian Rong; Diane Corey; Udo Hoffmann; Caroline S Fox; Ramachandran S Vasan; Emelia J Benjamin; Christopher J O'Donnell; Sekar Kathiresan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-06       Impact factor: 8.311

2.  High levels of osteoprotegerin are associated with coronary artery calcification in patients suspected of a chronic coronary syndrome.

Authors:  Mirthe Dekker; Farahnaz Waissi; Max J M Silvis; Joelle V Bennekom; Arjan H Schoneveld; Robbert J de Winter; Ivana Isgum; Nikolas Lessmann; Birgitta K Velthuis; Gerard Pasterkamp; Arend Mosterd; Leo Timmers; Dominique P V de Kleijn
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

3.  Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients.

Authors:  Zsofia K Nemeth; Nicoleta G Mardare; Maria E Czira; Gyorgy Deak; Istvan Kiss; Zoltan Mathe; Adam Remport; Akos Ujszaszi; Adrian Covic; Miklos Z Molnar; Istvan Mucsi
Journal:  Sci Rep       Date:  2015-10-13       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.